The HIt HArd and hiT Early in Multiple Sclerosis Trial - HiHat Trial A Phase 2 Study of Sequential Treatment With Rituximab and Cladribine for Relapsing-remitting Multiple Sclerosis
NCT07517185 · NOT YET RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Uppsala University. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Uppsala University.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Uppsala University currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Uppsala University conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.